In this article we discuss Bill Gates’ Most Recent Investments. If you want to skip our detailed discussion of the history and investments of the Bill & Melinda Gates Foundation Trust, go directly to Bill Gates’ 5 Most Recent Investments. The Bill & Melinda Gates Foundation was launched in 2000 by the American billionaire, philanthropist […]
Yahoo Finance's Andy Serwer is joined by Bill & Melinda Gates Foundation Co-chairman, Bill Gates, for a 30 minute discussion about his new book, How to Avoid a Climate Disaster, and why Gates says we've reached a crucial moment for the future of our planet.
パンドラの瓶：世界中のすべてのコロナウイルス粒子は炭酸飲料の瓶に入る＝研究調査 sputniknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sputniknews.com Daily Mail and Mail on Sunday newspapers.
MedinCell Announces Three New Products Entering Regulatory Development
mdc-GRT (organ transplant), mdc-KPT (pain animal health) and mdc-TTG (Covid-19)
The MedinCell team has selected
the lead formulation and started the regulatory preclinical development of those three programs.
« With the admission of three new products into preclinical development and the achievement of this milestone for our contraceptive program last April, our team has achieved its goals stated Christophe Douat, CEO of MedinCell
. The most advanced product of our portfolio whose pivotal Phase 3 ended with positive results is only the tip of the iceberg. On top of this product which is about to enter the final stage of the approval process, Phase 3 should start this year for two other products .
Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index
Wednesday, January 27, 2021 11:40AM IST (6:10AM GMT)
Company Ranked Sixth Overall and Leads the Pharmaceutical Industry in Governance of Access
Secured Industry-Leading Positions in All Three Technical Areas Evaluated
Shows Strong Performance in Health System Strengthening and Compliance
(TSE:4502/NYSE:TAK) (“Takeda”) has earned an industry-leading position within the 2021
Access to Medicine (AtM) Index published today. Specifically the company achieved notable, high scores in all three technical areas evaluated by the Index, including being ranked first in Governance of Access. Takeda also demonstrated strong performance in the areas of health system strengthening, compliance and R&D capacity building, according to the Index.